WA
CELG

Winfield Associates’s Celgene Corp CELG Stock Holding History

Winfield Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-165
Closed -$19K – 817
2017
Q4 		$19K Sell
165
-76
-32% -$8.57K 0.01% 324
2017
Q3 		$35K Buy
241
+6
+3% +$817 0.02% 225
2017
Q2 		$31K Buy
235
+65
+38% +$7.96K 0.02% 231
2017
Q1 		$21K Buy
170
+35
+26% +$4.19K 0.01% 264
2016
Q4 		$16K Sell
135
-30
-18% -$3.34K 0.01% 298
2016
Q3 		$17K Buy
165
+30
+22% +$3.25K 0.01% 276
2016
Q2 		$13K Buy
135
+75
+125% +$7.76K 0.01% 300
2016
Q1 		$6K Buy
+60
New +$6.18K ﹤0.01% 371

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Winfield Associates's CELG Position: Q1 2018 in Review

Winfield Associates sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 165 shares — an estimated $19K sold.

Winfield Associates first reported a position in CELG in Q1 2016 and held it in 8 quarters. The position peaked at $35K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Winfield Associates reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 165 Celgene Corp shares in Q1 2018, an estimated $19K.
  • Winfield Associates first reported a position in Celgene Corp in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Celgene Corp position peaked at $35K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.